Galic, V., Wright, J., Lewin, S., & Herzog, T. (2012). Erratum: Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666). Expert Opinion on Investigational Drugs, 21(7), 1067. https://doi.org/10.1517/13543784.2012.699224
Erratum: Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666). / Galic, Vijaya
; Wright, Jason; Lewin, Sharyn et al.
Dans:
Expert Opinion on Investigational Drugs, Vol. 21, N° 7, 07.2012, p. 1067.
Résultat de recherche › examen par les pairs
Galic, V, Wright, J, Lewin, S & Herzog, T 2012, 'Erratum: Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666)', Expert Opinion on Investigational Drugs, vol. 21, n° 7, pp. 1067. https://doi.org/10.1517/13543784.2012.699224
Galic V, Wright J, Lewin S, Herzog T. Erratum: Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666). Expert Opinion on Investigational Drugs. 2012 juill.;21(7):1067. doi: 10.1517/13543784.2012.699224
Galic, Vijaya ; Wright, Jason ; Lewin, Sharyn et al. / Erratum : Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666). Dans: Expert Opinion on Investigational Drugs. 2012 ; Vol. 21, N° 7. pp. 1067.
@article{230d3c68eda04a81bc073ea6cd6324cc,
title = "Erratum: Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666)",
author = "Vijaya Galic and Jason Wright and Sharyn Lewin and Thomas Herzog",
year = "2012",
month = jul,
doi = "10.1517/13543784.2012.699224",
language = "English",
volume = "21",
pages = "1067",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "7",
}
TY - JOUR
T1 - Erratum
T2 - Paclitaxel poliglumex for ovarian cancer (Expert Opinion on Investigational Drugs (2011) 20(6) (813-21) DOI: 10.1517/13543784.2011.576666)
AU - Galic, Vijaya
AU - Wright, Jason
AU - Lewin, Sharyn
AU - Herzog, Thomas
PY - 2012/7
Y1 - 2012/7
UR - http://www.scopus.com/inward/record.url?scp=84862303843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862303843&partnerID=8YFLogxK
U2 - 10.1517/13543784.2012.699224
DO - 10.1517/13543784.2012.699224
M3 - Comment/debate
AN - SCOPUS:84862303843
SN - 1354-3784
VL - 21
SP - 1067
JO - Expert Opinion on Investigational Drugs
JF - Expert Opinion on Investigational Drugs
IS - 7
ER -